MicroRNA-222 promotes drug resistance to doxorubicin in breast cancer via regulation of miR-222/bim pathway.

Dai, Hong; Xu, Ling-Yun; Qian, Qi; Zhu, Qiu-Wei; Chen, Wei-Xian

Dai, Hong; Xu, Ling-Yun; Qian, Qi; Zhu, Qiu-Wei; Chen, Wei-Xian.

Afiliação

Dai H; Department of Breast Surgery, the Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou 213000, China.
Xu LY; Department of Breast Surgery, the Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou 213000, China.
Qian Q; Department of Breast Surgery, the Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou 213000, China.
Zhu QW; Department of Breast Surgery, the Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou 213000, China chenweixian@njmu.edu.cn zhuqiuweidoc@outlook.com.
Chen WX; Department of Breast Surgery, the Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou 213000, China chenweixian@njmu.edu.cn zhuqiuweidoc@outlook.com.

Biosci Rep ; 39(7)2019 07 31.

Article em En | MEDLINE | ID: mdl-31273056

Assuntos

Neoplasias da Mama/metabolismo; Doxorrubicina/farmacologia; Resistencia a Medicamentos Antineoplásicos; MicroRNAs/metabolismo; RNA Neoplásico/metabolismo; Transdução de Sinais; Neoplasias da Mama/genética; Neoplasias da Mama/patologia; Feminino; Humanos; Células MCF-7; MicroRNAs/genética; RNA Neoplásico/genética

Palavras-chave

Breast cancer; Chemoresistance; Doxorubicin; miR-222

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / RNA Neoplásico / Transdução de Sinais / Doxorrubicina / Resistencia a Medicamentos Antineoplásicos / MicroRNAs Limite: Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google